Original Article

You have full text access to this OnlineOpen article

Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma

  1. Helga B. Salvesen M.D., Ph.D.1,2,†,*,
  2. Ingunn Stefansson M.D.1,
  3. May Britt Kalvenes Ph.D.1,
  4. Soma Das Ph.D.3,
  5. Lars A. Akslen M.D., Ph.D.1

Article first published online: 15 APR 2002

DOI: 10.1002/cncr.10434

Issue

Cancer

Cancer

Volume 94, Issue 8, pages 2185–2191, 15 April 2002

Additional Information

How to Cite

Salvesen, H. B., Stefansson, I., Kalvenes, M. B., Das, S. and Akslen, L. A. (2002), Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma. Cancer, 94: 2185–2191. doi: 10.1002/cncr.10434

Author Information

  1. 1

    Department of Pathology, The Gade Institute, Haukeland University Hospital, Bergen, Norway

  2. 2

    Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway

  3. 3

    Department of Human Genetics, The University of Chicago, Chicago, Illinois

  1. †

    Fax: 47 55 97 49 68

*Department of Gynecology and Obstetrics, Haukeland University Hospital, N-5021 Bergen, Norway

Publication History

  1. Issue published online: 15 APR 2002
  2. Article first published online: 15 APR 2002
  3. Manuscript Accepted: 9 NOV 2001
  4. Manuscript Revised: 16 OCT 2001
  5. Manuscript Received: 31 JUL 2001

Funded by

  • Norske Kvinners Sanitetsforening, the Norwegian Cancer Society. Grant Number: D96032/D94070
  • National Institutes of Health. Grant Number: CA81652-01
  • Blix Family Fund
  • Elena and Gustav B. Bull's Legacy

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (2353K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Tie-Zhong Yi, Jing Guo, Lili Zhou, Xing Chen, Ruo-Ran Mi, Quan-Xin Qu, Jian-Hua Zheng, Ling Zhai, Prognostic Value of E-Cadherin Expression and CDH1 Promoter Methylation in Patients With Endometrial Carcinoma, Cancer Investigation, 2011, 29, 1, 86

    CrossRef

  2. 2
    Bojana Djordjevic, Russell R. Broaddus, Selected Topics in the Molecular Pathology of Endometrial Carcinoma, Surgical Pathology Clinics, 2011, 4, 1, 131

    CrossRef

  3. 3
    Liu Yuhuan, Wang Jiaqi, Yang Peili, Hu Jingjing, Chen Chao, Ji Mei, Hui Ning, Yu Chaoqin, Cai Zailong, Adenovirus-mediated PTEN gene transfection suppresses growth and promotes chemosensitivity of endometrial carcinoma, Journal of Medical Colleges of PLA, 2010, 25, 4, 193

    CrossRef

  4. 4
    Ainara Azueta, Sonia Gatius, Xavier Matias-Guiu, Endometrioid carcinoma of the endometrium: pathologic and molecular features, Seminars in Diagnostic Pathology, 2010, 27, 4, 226

    CrossRef

  5. 5
    Zhicai Zhang, Zengwu Shao, Liming Xiong, Biao Che, Chao Deng, Weiwei Xu, Expression of Beclin1 in osteosarcoma and the effects of down-regulation of autophagy on the chemotherapeutic sensitivity, Journal of Huazhong University of Science and Technology [Medical Sciences], 2009, 29, 6, 737

    CrossRef

  6. 6
    H. B. Salvesen, S. L. Carter, M. Mannelqvist, A. Dutt, G. Getz, I. M. Stefansson, M. B. Raeder, M. L. Sos, I. B. Engelsen, J. Trovik, E. Wik, H. Greulich, T. H. Bo, I. Jonassen, R. K. Thomas, T. Zander, L. A. Garraway, A. M. Oyan, W. R. Sellers, K. H. Kalland, M. Meyerson, L. A. Akslen, R. Beroukhim, Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation, Proceedings of the National Academy of Sciences, 2009, 106, 12, 4834

    CrossRef

  7. 7
    Ole Johan Halvorsen, Molecular and prognostic markers in prostate cancer, APMIS, 2008, 116,
    Direct Link:
  8. 8
    Nilgun Kapucuoglu, Fatma Aktepe, Hakan Kaya, Sema Bircan, Nermin Karahan, Metin Çiriş, Immunohistochemical expression of PTEN in normal, hyperplastic and malignant endometrium and its correlation with hormone receptors, bcl-2, bax, and apoptotic index, Pathology - Research and Practice, 2007, 203, 3, 153

    CrossRef

  9. 9
    Catherine S.M. Diefenbach, Zharna Shah, Alexia Iasonos, Richard R. Barakat, Douglas A. Levine, Carol Aghajanian, Paul Sabbatini, Martee L. Hensley, Jason Konner, William Tew, David Spriggs, Martin Fleisher, Howard Thaler, Jakob Dupont, Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer, Gynecologic Oncology, 2007, 104, 2, 435

    CrossRef

  10. 10
    D. Chang, T.-Y. Wang, H.-C. Li, J.-C. Wei, J.-X. Song, Prognostic significance of PTEN expression in esophageal squamous cell carcinoma from Linzhou City, a high incidence area of northern China, Diseases of the Esophagus, 2007, 20, 6
    Direct Link:
  11. 11
    Tommaso Susini, Gianni Amunni, Cecilia Molino, Carlo Carriero, Stefano Rapi, Francesco Branconi, Mauro Marchionni, Gianluigi Taddei, Gianfranco Scarselli, Ten-year results of a prospective study on the prognostic role of ploidy in endometrial carcinoma, Cancer, 2007, 109, 5
    Direct Link:
  12. 12
    P. ATHANASSIADOU, P. ATHANASSIADES, D. GRAPSA, M. GONIDI, A.M. ATHANASSIADOU, P.N. STAMATI, E. PATSOURIS, The prognostic value of PTEN, p53, and beta-catenin in endometrial carcinoma: a prospective immunocytochemical study, International Journal of Gynecological Cancer, 2007, 17, 3
    Direct Link:
  13. 13
    Laurel W. Rice, Rebecca L. Stone, Miaohou Xu, Mary Galgano, Mark H. Stoler, Elise N. Everett, Amir A. Jazaeri, Biologic targets for therapeutic intervention in endometrioid endometrial adenocarcinoma and malignant mixed müllerian tumors, American Journal of Obstetrics and Gynecology, 2006, 194, 4, 1119

    CrossRef

  14. 14
    Ji Shin Lee, Yoo Duk Choi, Jae Hyuk Lee, Jong Hee Nam, Chan Choi, Min Cheol Lee, Chang Soo Park, Hyung Seok Kim, Kyung Whan Min, Expression of PTEN in the progression of cervical neoplasia and its relation to tumor behavior and angiogenesis in invasive squamous cell carcinoma, Journal of Surgical Oncology, 2006, 93, 3
    Direct Link:
  15. 15
    Ingunn M. Stefansson, Helga B. Salvesen, Lars A. Akslen, Loss of p63 and cytokeratin 5/6 expression is associated with more aggressive tumors in endometrial carcinoma patients, International Journal of Cancer, 2006, 118, 5
    Direct Link:
  16. 16
    L.H. HONOR?, J. HANSON, S.E. ANDREW, Microsatellite instability in endometrioid endometrial carcinoma: correlation with clinically relevant pathologic variables, International Journal of Gynecological Cancer, 2006, 16, 3
    Direct Link:
  17. 17
    Shinichi Tsutsui, Hiroshi Inoue, Kazuhiro Yasuda, Kosuke Suzuki, Hidefumi Higashi, Shoichi Era, Masaki Mori, Reduced Expression of PTEN Protein and Its Prognostic Implications in Invasive Ductal Carcinoma of the Breast, Oncology, 2005, 68, 4-6, 398

    CrossRef

  18. 18
    Judit Pallares, Jose Luis Mart??nez-Guitarte, Xavier Dolcet, David Llobet, Montserrat Rue, Jos?? Palacios, Jaime Prat, Xavier Matias-Guiu, Survivin Expression in Endometrial Carcinoma:, International Journal of Gynecological Pathology, 2005, 24, 3, 247

    CrossRef

  19. 19
    Danielle B. Lane, Thomas J. Rutherford, Hugh S. Taylor, HOXA10 Expression in Endometrial Adenocarcinoma, Tumor Biology, 2004, 25, 5-6, 264

    CrossRef

  20. 20
    Judit Pallares, Elena Bussaglia, Jose Luis Martínez-Guitarte, Xavier Dolcet, David Llobet, Montserrat Rue, Lidia Sanchez-Verde, Jose Palacios, Jaime Prat, Xavier Matias-Guiu, Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities, Modern Pathology, 2004, 18, 5, 719

    CrossRef

  21. 21
    Myoung Ja Chung, Sung Hoo Jung, Bong Ju Lee, Myoung Jae Kang, Dong Geun Lee, Inactivation of the PTEN gene protein product is associated with the invasiveness and metastasis, but not angiogenesis, of breast cancer, Pathology International, 2004, 54, 1
    Direct Link:
  22. 22
    N. D. Macdonald, H. B. Salvesen, A. Ryan, S. Malatos, I. Stefansson, O. E. Iversen, L. A. Akslen, S. Das, I. J. Jacobs, Molecular differences between RER+ and RER– sporadic endometrial carcinomas in a large population-based series, International Journal of Gynecological Cancer, 2004, 14, 5
    Direct Link:
  23. 23
    Ji Shin Lee, Hyung Seok Kim, Young Bog Kim, Min Cheol Lee, Chang Soo Park, Kyung Whan Min, Reduced PTEN Expression Is Associated With Poor Outcome and Angiogenesis in Invasive Ductal Carcinoma of the Breast, Applied Immunohistochemistry & Molecular Morphology, 2004, 12, 3, 205

    CrossRef

  24. 24
    B. B. Y. Ma, A. Oza, E. Eisenhauer, G. Stanimir, M. Carey, W. Chapman, E. Latta, K. Sidhu, J. Powers, W. Walsh, A. Fyles, The activity of letrozole in patients with advanced or recurrent endometrial cancer and correlation with biological markers – a study of the National Cancer Institute of Canada Clinical Trials Group, International Journal of Gynecological Cancer, 2004, 14, 4
    Direct Link:
  25. 25
    Ji Shin Lee, Hyung Seok Kim, Young Bok Kim, Min Cheol Lee, Chang Soo Park, Expression of PTEN in renal cell carcinoma and its relation to tumor behavior and growth, Journal of Surgical Oncology, 2003, 84, 3
    Direct Link:
  26. 26
    Gloria PeirÓ, MD, Peter Lohse, MD, Doris Mayr, MD, Joachim Diebold, MD, Insulin-like Growth Factor-I Receptor and PTEN Protein Expression in Endometrial Carcinoma: Correlation With bax and bcl-2 Expression, Microsatellite Instability Status, and Outcome, American Journal of Clinical Pathology, 2003, 120, 1, 78

    CrossRef

  27. 27
    Farhad Alexander-Sefre, Helga B. Salvesen, Andy Ryan, Naveena Singh, Lars A. Akslen, Nicolla MacDonald, George Wilbanks, Ian J. Jacobs, Molecular assessment of depth of myometrial invasion in stage I endometrial cancer: a model based on K-ras mutation analysis, Gynecologic Oncology, 2003, 91, 1, 218

    CrossRef

  28. 28
    HELGA B. SALVESEN, LARS A. AKSLEN, Molecular pathogenesis and prognostic factors in endometrial carcinoma, APMIS, 2002, 110, 10
    Direct Link:
View Full Article (HTML) Get PDF (2353K)